Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$63,000.00

LEISH-INSIGHT: Decoding AMR and fitness compensatory mechanisms in protozoan parasites of the genus Leishmania

FY 2024-25

Summary
The protozoan parasite Leishmania infantum causes a life-threatening, chronic, incurable disease called canine leishmaniosis in dogs. Despite many vaccine-development efforts have been carried during the last decade, none of has raised as a true alternative to chemotherapy in dogs. In the absence of new drugs introduced in the recent years, current treatments are restricted to only two drugs, old-fashioned antimonial derivatives, and antitumor drug miltefosine. Another issue is that the current antileishmanials neither have a clear mechanism of action nor a clear mechanism of resistance. The long-term objective of our program is to advance our understanding of the molecular and cellular processes underlying the development and spread of antimicrobial resistance (AMR) in Leishmania populations. Our scientific approach is based on the hypothesis that Leishmania employs previously unidentified AMR mechanisms and general homeostasis processes to survive drug treatments. This enhances the parasite's adaptability and fitness but leaves lasting genetic imprints even after resistance is lost. We also propose that AMR parasites exhibit distinct activation patterns within host cells, allowing them to persist in a dormant state. Over the next five years, we will investigate: i) potential AMR mechanisms against allopurinol derivatives and synthetic antimicrobial peptides through experimental evolution coupled functional genomics; ii) the impact of resistance to antimony and miltefosine on parasite quiescence and survival within host cells. We will focus on understanding the molecular factors that drive Leishmania into a dormant state and how AMR affects this process using different cellular and genomic approaches; and iii) how the loss of AMR, upon removal of drug pressure, affects the vulnerability of the parasite to other stressors, such as host immune responses or sensitivity to other drugs. The expected novelty and significance of our research program include: i) discovering and understanding new genes and pathways involved in AMR in Leishmania; ii) providing novel insights into how Leishmania maintains homeostasis when exposed to different stressors; iii) generating fundamental knowledge about the trade-offs associated with AMR; and iv) gaining a deeper understanding of how AMR parasites interact with their hosts. Furthermore, our program is committed to training highly qualified individuals with diverse expertise, equipped to make substantial global contributions in the fields of fundamental research, parasitology, and antimicrobial resistance.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-04103
Name nom
Fernandez Prada, Christopher
Department département
Pathologie et microbiologie/Faculté de médecine vétérinaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
63000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5203
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Protozoology
Research subject fr
Protozoologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
LEISH-INSIGHT: Decoding AMR and fitness compensatory mechanisms in protozoan parasites of the genus Leishmania
Keywords
antimicrobial resistance; protozoan parasites; leishmania; genomics; transcriptomics; host-parasite interaction; phenotypic plasticity; re-sensitazion to antimicrobials; fitness cost; leishmania homeostasis mechanisms
Application summary
The protozoan parasite Leishmania infantum causes a life-threatening, chronic, incurable disease called canine leishmaniosis in dogs. Despite many vaccine-development efforts have been carried during the last decade, none of has raised as a true alternative to chemotherapy in dogs. In the absence of new drugs introduced in the recent years, current treatments are restricted to only two drugs, old-fashioned antimonial derivatives, and antitumor drug miltefosine. Another issue is that the current antileishmanials neither have a clear mechanism of action nor a clear mechanism of resistance. The long-term objective of our program is to advance our understanding of the molecular and cellular processes underlying the development and spread of antimicrobial resistance (AMR) in Leishmania populations. Our scientific approach is based on the hypothesis that Leishmania employs previously unidentified AMR mechanisms and general homeostasis processes to survive drug treatments. This enhances the parasite's adaptability and fitness but leaves lasting genetic imprints even after resistance is lost. We also propose that AMR parasites exhibit distinct activation patterns within host cells, allowing them to persist in a dormant state. Over the next five years, we will investigate: i) potential AMR mechanisms against allopurinol derivatives and synthetic antimicrobial peptides through experimental evolution coupled functional genomics; ii) the impact of resistance to antimony and miltefosine on parasite quiescence and survival within host cells. We will focus on understanding the molecular factors that drive Leishmania into a dormant state and how AMR affects this process using different cellular and genomic approaches; and iii) how the loss of AMR, upon removal of drug pressure, affects the vulnerability of the parasite to other stressors, such as host immune responses or sensitivity to other drugs. The expected novelty and significance of our research program include: i) discovering and understanding new genes and pathways involved in AMR in Leishmania; ii) providing novel insights into how Leishmania maintains homeostasis when exposed to different stressors; iii) generating fundamental knowledge about the trade-offs associated with AMR; and iv) gaining a deeper understanding of how AMR parasites interact with their hosts. Furthermore, our program is committed to training highly qualified individuals with diverse expertise, equipped to make substantial global contributions in the fields of fundamental research, parasitology, and antimicrobial resistance.
Université de Montréal - $63,000 Grant (2024-25) | Canada Spends